nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifaximin—CYP3A4—Thiotepa—sarcoma	0.227	0.458	CbGbCtD
Rifaximin—CYP3A4—Mitoxantrone—sarcoma	0.0976	0.197	CbGbCtD
Rifaximin—CYP3A4—Vincristine—sarcoma	0.0671	0.136	CbGbCtD
Rifaximin—CYP3A4—Etoposide—sarcoma	0.0615	0.124	CbGbCtD
Rifaximin—CYP3A4—Doxorubicin—sarcoma	0.042	0.0847	CbGbCtD
Rifaximin—Hypoglycaemia—Doxorubicin—sarcoma	0.00099	0.00196	CcSEcCtD
Rifaximin—Loss of consciousness—Etoposide—sarcoma	0.000986	0.00195	CcSEcCtD
Rifaximin—Decreased appetite—Vincristine—sarcoma	0.000982	0.00195	CcSEcCtD
Rifaximin—Dyspnoea—Mitoxantrone—sarcoma	0.000981	0.00194	CcSEcCtD
Rifaximin—Cough—Etoposide—sarcoma	0.000978	0.00194	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Vincristine—sarcoma	0.000975	0.00193	CcSEcCtD
Rifaximin—Fatigue—Vincristine—sarcoma	0.000974	0.00193	CcSEcCtD
Rifaximin—Dehydration—Epirubicin—sarcoma	0.000971	0.00192	CcSEcCtD
Rifaximin—Hyponatraemia—Doxorubicin—sarcoma	0.00097	0.00192	CcSEcCtD
Rifaximin—Pain—Vincristine—sarcoma	0.000966	0.00191	CcSEcCtD
Rifaximin—Constipation—Vincristine—sarcoma	0.000966	0.00191	CcSEcCtD
Rifaximin—Pain in extremity—Doxorubicin—sarcoma	0.000966	0.00191	CcSEcCtD
Rifaximin—Decreased appetite—Mitoxantrone—sarcoma	0.000956	0.00189	CcSEcCtD
Rifaximin—Chest pain—Etoposide—sarcoma	0.000955	0.00189	CcSEcCtD
Rifaximin—Abdominal pain upper—Epirubicin—sarcoma	0.000953	0.00189	CcSEcCtD
Rifaximin—Migraine—Doxorubicin—sarcoma	0.000951	0.00188	CcSEcCtD
Rifaximin—Fatigue—Mitoxantrone—sarcoma	0.000949	0.00188	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000948	0.00188	CcSEcCtD
Rifaximin—Discomfort—Etoposide—sarcoma	0.000943	0.00187	CcSEcCtD
Rifaximin—Pain—Mitoxantrone—sarcoma	0.000941	0.00186	CcSEcCtD
Rifaximin—Constipation—Mitoxantrone—sarcoma	0.000941	0.00186	CcSEcCtD
Rifaximin—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.00094	0.00186	CcSEcCtD
Rifaximin—Hypersensitivity—Thiotepa—sarcoma	0.000939	0.00186	CcSEcCtD
Rifaximin—Nasopharyngitis—Epirubicin—sarcoma	0.000933	0.00185	CcSEcCtD
Rifaximin—Hypersensitivity—Dactinomycin—sarcoma	0.000932	0.00185	CcSEcCtD
Rifaximin—Gastrointestinal pain—Vincristine—sarcoma	0.000924	0.00183	CcSEcCtD
Rifaximin—Confusional state—Etoposide—sarcoma	0.000923	0.00183	CcSEcCtD
Rifaximin—Anaphylactic shock—Etoposide—sarcoma	0.000915	0.00181	CcSEcCtD
Rifaximin—Asthenia—Thiotepa—sarcoma	0.000914	0.00181	CcSEcCtD
Rifaximin—Infection—Etoposide—sarcoma	0.000909	0.0018	CcSEcCtD
Rifaximin—Abdominal distension—Epirubicin—sarcoma	0.000908	0.0018	CcSEcCtD
Rifaximin—Asthenia—Dactinomycin—sarcoma	0.000907	0.0018	CcSEcCtD
Rifaximin—Feeling abnormal—Mitoxantrone—sarcoma	0.000907	0.0018	CcSEcCtD
Rifaximin—Dysphagia—Epirubicin—sarcoma	0.000902	0.00179	CcSEcCtD
Rifaximin—Pruritus—Thiotepa—sarcoma	0.000901	0.00179	CcSEcCtD
Rifaximin—Gastrointestinal pain—Mitoxantrone—sarcoma	0.0009	0.00178	CcSEcCtD
Rifaximin—Dehydration—Doxorubicin—sarcoma	0.000898	0.00178	CcSEcCtD
Rifaximin—Abdominal pain—Vincristine—sarcoma	0.000893	0.00177	CcSEcCtD
Rifaximin—Body temperature increased—Vincristine—sarcoma	0.000893	0.00177	CcSEcCtD
Rifaximin—Skin disorder—Etoposide—sarcoma	0.000889	0.00176	CcSEcCtD
Rifaximin—Hyperhidrosis—Etoposide—sarcoma	0.000885	0.00175	CcSEcCtD
Rifaximin—Abdominal pain upper—Doxorubicin—sarcoma	0.000882	0.00175	CcSEcCtD
Rifaximin—Urticaria—Mitoxantrone—sarcoma	0.000874	0.00173	CcSEcCtD
Rifaximin—Anorexia—Etoposide—sarcoma	0.000872	0.00173	CcSEcCtD
Rifaximin—Diarrhoea—Thiotepa—sarcoma	0.000872	0.00173	CcSEcCtD
Rifaximin—Abdominal pain—Mitoxantrone—sarcoma	0.00087	0.00172	CcSEcCtD
Rifaximin—Body temperature increased—Mitoxantrone—sarcoma	0.00087	0.00172	CcSEcCtD
Rifaximin—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.00087	0.00172	CcSEcCtD
Rifaximin—Diarrhoea—Dactinomycin—sarcoma	0.000865	0.00171	CcSEcCtD
Rifaximin—Nasopharyngitis—Doxorubicin—sarcoma	0.000864	0.00171	CcSEcCtD
Rifaximin—Hypotension—Etoposide—sarcoma	0.000855	0.00169	CcSEcCtD
Rifaximin—Dysuria—Epirubicin—sarcoma	0.000844	0.00167	CcSEcCtD
Rifaximin—Neutropenia—Epirubicin—sarcoma	0.000844	0.00167	CcSEcCtD
Rifaximin—Dizziness—Thiotepa—sarcoma	0.000842	0.00167	CcSEcCtD
Rifaximin—Abdominal distension—Doxorubicin—sarcoma	0.00084	0.00166	CcSEcCtD
Rifaximin—Upper respiratory tract infection—Epirubicin—sarcoma	0.000838	0.00166	CcSEcCtD
Rifaximin—Dysphagia—Doxorubicin—sarcoma	0.000835	0.00165	CcSEcCtD
Rifaximin—Pollakiuria—Epirubicin—sarcoma	0.000833	0.00165	CcSEcCtD
Rifaximin—Hypersensitivity—Vincristine—sarcoma	0.000832	0.00165	CcSEcCtD
Rifaximin—Photosensitivity reaction—Epirubicin—sarcoma	0.000823	0.00163	CcSEcCtD
Rifaximin—Weight increased—Epirubicin—sarcoma	0.000821	0.00163	CcSEcCtD
Rifaximin—Weight decreased—Epirubicin—sarcoma	0.000816	0.00162	CcSEcCtD
Rifaximin—Dyspnoea—Etoposide—sarcoma	0.000816	0.00162	CcSEcCtD
Rifaximin—Hyperglycaemia—Epirubicin—sarcoma	0.000814	0.00161	CcSEcCtD
Rifaximin—Hypersensitivity—Mitoxantrone—sarcoma	0.000811	0.00161	CcSEcCtD
Rifaximin—Asthenia—Vincristine—sarcoma	0.000811	0.00161	CcSEcCtD
Rifaximin—Vomiting—Thiotepa—sarcoma	0.00081	0.0016	CcSEcCtD
Rifaximin—Pneumonia—Epirubicin—sarcoma	0.000809	0.0016	CcSEcCtD
Rifaximin—Infestation NOS—Epirubicin—sarcoma	0.000804	0.00159	CcSEcCtD
Rifaximin—Infestation—Epirubicin—sarcoma	0.000804	0.00159	CcSEcCtD
Rifaximin—Vomiting—Dactinomycin—sarcoma	0.000804	0.00159	CcSEcCtD
Rifaximin—Rash—Thiotepa—sarcoma	0.000803	0.00159	CcSEcCtD
Rifaximin—Dermatitis—Thiotepa—sarcoma	0.000803	0.00159	CcSEcCtD
Rifaximin—Headache—Thiotepa—sarcoma	0.000798	0.00158	CcSEcCtD
Rifaximin—Rash—Dactinomycin—sarcoma	0.000797	0.00158	CcSEcCtD
Rifaximin—Decreased appetite—Etoposide—sarcoma	0.000796	0.00158	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Etoposide—sarcoma	0.00079	0.00157	CcSEcCtD
Rifaximin—Asthenia—Mitoxantrone—sarcoma	0.000789	0.00156	CcSEcCtD
Rifaximin—Fatigue—Etoposide—sarcoma	0.000789	0.00156	CcSEcCtD
Rifaximin—Pain—Etoposide—sarcoma	0.000783	0.00155	CcSEcCtD
Rifaximin—Constipation—Etoposide—sarcoma	0.000783	0.00155	CcSEcCtD
Rifaximin—Dysuria—Doxorubicin—sarcoma	0.00078	0.00155	CcSEcCtD
Rifaximin—Neutropenia—Doxorubicin—sarcoma	0.00078	0.00155	CcSEcCtD
Rifaximin—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000776	0.00154	CcSEcCtD
Rifaximin—Diarrhoea—Vincristine—sarcoma	0.000773	0.00153	CcSEcCtD
Rifaximin—Pollakiuria—Doxorubicin—sarcoma	0.000771	0.00153	CcSEcCtD
Rifaximin—Haematuria—Epirubicin—sarcoma	0.000767	0.00152	CcSEcCtD
Rifaximin—Photosensitivity reaction—Doxorubicin—sarcoma	0.000762	0.00151	CcSEcCtD
Rifaximin—Weight increased—Doxorubicin—sarcoma	0.00076	0.0015	CcSEcCtD
Rifaximin—Epistaxis—Epirubicin—sarcoma	0.000759	0.0015	CcSEcCtD
Rifaximin—Nausea—Thiotepa—sarcoma	0.000757	0.0015	CcSEcCtD
Rifaximin—Weight decreased—Doxorubicin—sarcoma	0.000755	0.0015	CcSEcCtD
Rifaximin—Feeling abnormal—Etoposide—sarcoma	0.000754	0.00149	CcSEcCtD
Rifaximin—Hyperglycaemia—Doxorubicin—sarcoma	0.000753	0.00149	CcSEcCtD
Rifaximin—Diarrhoea—Mitoxantrone—sarcoma	0.000753	0.00149	CcSEcCtD
Rifaximin—Nausea—Dactinomycin—sarcoma	0.000751	0.00149	CcSEcCtD
Rifaximin—Pneumonia—Doxorubicin—sarcoma	0.000749	0.00148	CcSEcCtD
Rifaximin—Gastrointestinal pain—Etoposide—sarcoma	0.000748	0.00148	CcSEcCtD
Rifaximin—Dizziness—Vincristine—sarcoma	0.000747	0.00148	CcSEcCtD
Rifaximin—Infestation NOS—Doxorubicin—sarcoma	0.000744	0.00147	CcSEcCtD
Rifaximin—Infestation—Doxorubicin—sarcoma	0.000744	0.00147	CcSEcCtD
Rifaximin—Urticaria—Etoposide—sarcoma	0.000727	0.00144	CcSEcCtD
Rifaximin—Haemoglobin—Epirubicin—sarcoma	0.000726	0.00144	CcSEcCtD
Rifaximin—Rhinitis—Epirubicin—sarcoma	0.000724	0.00143	CcSEcCtD
Rifaximin—Body temperature increased—Etoposide—sarcoma	0.000723	0.00143	CcSEcCtD
Rifaximin—Abdominal pain—Etoposide—sarcoma	0.000723	0.00143	CcSEcCtD
Rifaximin—Haemorrhage—Epirubicin—sarcoma	0.000722	0.00143	CcSEcCtD
Rifaximin—Hypoaesthesia—Epirubicin—sarcoma	0.000718	0.00142	CcSEcCtD
Rifaximin—Vomiting—Vincristine—sarcoma	0.000718	0.00142	CcSEcCtD
Rifaximin—Pharyngitis—Epirubicin—sarcoma	0.000717	0.00142	CcSEcCtD
Rifaximin—Urinary tract disorder—Epirubicin—sarcoma	0.000713	0.00141	CcSEcCtD
Rifaximin—Rash—Vincristine—sarcoma	0.000712	0.00141	CcSEcCtD
Rifaximin—Dermatitis—Vincristine—sarcoma	0.000712	0.00141	CcSEcCtD
Rifaximin—Oedema peripheral—Epirubicin—sarcoma	0.000711	0.00141	CcSEcCtD
Rifaximin—Haematuria—Doxorubicin—sarcoma	0.00071	0.00141	CcSEcCtD
Rifaximin—Urethral disorder—Epirubicin—sarcoma	0.000708	0.0014	CcSEcCtD
Rifaximin—Headache—Vincristine—sarcoma	0.000708	0.0014	CcSEcCtD
Rifaximin—Epistaxis—Doxorubicin—sarcoma	0.000702	0.00139	CcSEcCtD
Rifaximin—Vomiting—Mitoxantrone—sarcoma	0.0007	0.00139	CcSEcCtD
Rifaximin—Rash—Mitoxantrone—sarcoma	0.000694	0.00137	CcSEcCtD
Rifaximin—Dermatitis—Mitoxantrone—sarcoma	0.000693	0.00137	CcSEcCtD
Rifaximin—Headache—Mitoxantrone—sarcoma	0.000689	0.00137	CcSEcCtD
Rifaximin—Hypersensitivity—Etoposide—sarcoma	0.000674	0.00134	CcSEcCtD
Rifaximin—Tinnitus—Epirubicin—sarcoma	0.000673	0.00133	CcSEcCtD
Rifaximin—Haemoglobin—Doxorubicin—sarcoma	0.000671	0.00133	CcSEcCtD
Rifaximin—Nausea—Vincristine—sarcoma	0.000671	0.00133	CcSEcCtD
Rifaximin—Flushing—Epirubicin—sarcoma	0.00067	0.00133	CcSEcCtD
Rifaximin—Rhinitis—Doxorubicin—sarcoma	0.00067	0.00133	CcSEcCtD
Rifaximin—Haemorrhage—Doxorubicin—sarcoma	0.000668	0.00132	CcSEcCtD
Rifaximin—Hypoaesthesia—Doxorubicin—sarcoma	0.000665	0.00132	CcSEcCtD
Rifaximin—Pharyngitis—Doxorubicin—sarcoma	0.000663	0.00131	CcSEcCtD
Rifaximin—Urinary tract disorder—Doxorubicin—sarcoma	0.00066	0.00131	CcSEcCtD
Rifaximin—Oedema peripheral—Doxorubicin—sarcoma	0.000658	0.0013	CcSEcCtD
Rifaximin—Asthenia—Etoposide—sarcoma	0.000657	0.0013	CcSEcCtD
Rifaximin—Angiopathy—Epirubicin—sarcoma	0.000655	0.0013	CcSEcCtD
Rifaximin—Urethral disorder—Doxorubicin—sarcoma	0.000655	0.0013	CcSEcCtD
Rifaximin—Nausea—Mitoxantrone—sarcoma	0.000653	0.00129	CcSEcCtD
Rifaximin—Mediastinal disorder—Epirubicin—sarcoma	0.000651	0.00129	CcSEcCtD
Rifaximin—Pruritus—Etoposide—sarcoma	0.000647	0.00128	CcSEcCtD
Rifaximin—Mental disorder—Epirubicin—sarcoma	0.000633	0.00125	CcSEcCtD
Rifaximin—Malnutrition—Epirubicin—sarcoma	0.000629	0.00125	CcSEcCtD
Rifaximin—Diarrhoea—Etoposide—sarcoma	0.000626	0.00124	CcSEcCtD
Rifaximin—Tinnitus—Doxorubicin—sarcoma	0.000623	0.00123	CcSEcCtD
Rifaximin—Flushing—Doxorubicin—sarcoma	0.00062	0.00123	CcSEcCtD
Rifaximin—Flatulence—Epirubicin—sarcoma	0.000619	0.00123	CcSEcCtD
Rifaximin—Back pain—Epirubicin—sarcoma	0.000608	0.0012	CcSEcCtD
Rifaximin—Angiopathy—Doxorubicin—sarcoma	0.000606	0.0012	CcSEcCtD
Rifaximin—Dizziness—Etoposide—sarcoma	0.000605	0.0012	CcSEcCtD
Rifaximin—Muscle spasms—Epirubicin—sarcoma	0.000604	0.0012	CcSEcCtD
Rifaximin—Mediastinal disorder—Doxorubicin—sarcoma	0.000602	0.00119	CcSEcCtD
Rifaximin—Mental disorder—Doxorubicin—sarcoma	0.000585	0.00116	CcSEcCtD
Rifaximin—Ill-defined disorder—Epirubicin—sarcoma	0.000583	0.00116	CcSEcCtD
Rifaximin—Vomiting—Etoposide—sarcoma	0.000582	0.00115	CcSEcCtD
Rifaximin—Malnutrition—Doxorubicin—sarcoma	0.000582	0.00115	CcSEcCtD
Rifaximin—Anaemia—Epirubicin—sarcoma	0.000581	0.00115	CcSEcCtD
Rifaximin—Rash—Etoposide—sarcoma	0.000577	0.00114	CcSEcCtD
Rifaximin—Dermatitis—Etoposide—sarcoma	0.000576	0.00114	CcSEcCtD
Rifaximin—Headache—Etoposide—sarcoma	0.000573	0.00114	CcSEcCtD
Rifaximin—Flatulence—Doxorubicin—sarcoma	0.000573	0.00114	CcSEcCtD
Rifaximin—Malaise—Epirubicin—sarcoma	0.000567	0.00112	CcSEcCtD
Rifaximin—Vertigo—Epirubicin—sarcoma	0.000565	0.00112	CcSEcCtD
Rifaximin—Syncope—Epirubicin—sarcoma	0.000564	0.00112	CcSEcCtD
Rifaximin—Back pain—Doxorubicin—sarcoma	0.000563	0.00111	CcSEcCtD
Rifaximin—Muscle spasms—Doxorubicin—sarcoma	0.000559	0.00111	CcSEcCtD
Rifaximin—Loss of consciousness—Epirubicin—sarcoma	0.000552	0.00109	CcSEcCtD
Rifaximin—Cough—Epirubicin—sarcoma	0.000548	0.00109	CcSEcCtD
Rifaximin—Nausea—Etoposide—sarcoma	0.000544	0.00108	CcSEcCtD
Rifaximin—Ill-defined disorder—Doxorubicin—sarcoma	0.00054	0.00107	CcSEcCtD
Rifaximin—Anaemia—Doxorubicin—sarcoma	0.000538	0.00107	CcSEcCtD
Rifaximin—Arthralgia—Epirubicin—sarcoma	0.000535	0.00106	CcSEcCtD
Rifaximin—Myalgia—Epirubicin—sarcoma	0.000535	0.00106	CcSEcCtD
Rifaximin—Chest pain—Epirubicin—sarcoma	0.000535	0.00106	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000531	0.00105	CcSEcCtD
Rifaximin—Discomfort—Epirubicin—sarcoma	0.000529	0.00105	CcSEcCtD
Rifaximin—Malaise—Doxorubicin—sarcoma	0.000524	0.00104	CcSEcCtD
Rifaximin—Dry mouth—Epirubicin—sarcoma	0.000523	0.00104	CcSEcCtD
Rifaximin—Vertigo—Doxorubicin—sarcoma	0.000523	0.00104	CcSEcCtD
Rifaximin—Syncope—Doxorubicin—sarcoma	0.000522	0.00103	CcSEcCtD
Rifaximin—Confusional state—Epirubicin—sarcoma	0.000517	0.00102	CcSEcCtD
Rifaximin—Anaphylactic shock—Epirubicin—sarcoma	0.000513	0.00102	CcSEcCtD
Rifaximin—Loss of consciousness—Doxorubicin—sarcoma	0.000511	0.00101	CcSEcCtD
Rifaximin—Infection—Epirubicin—sarcoma	0.00051	0.00101	CcSEcCtD
Rifaximin—Cough—Doxorubicin—sarcoma	0.000507	0.00101	CcSEcCtD
Rifaximin—Shock—Epirubicin—sarcoma	0.000505	0.001	CcSEcCtD
Rifaximin—Nervous system disorder—Epirubicin—sarcoma	0.000503	0.000997	CcSEcCtD
Rifaximin—Skin disorder—Epirubicin—sarcoma	0.000498	0.000987	CcSEcCtD
Rifaximin—Hyperhidrosis—Epirubicin—sarcoma	0.000496	0.000983	CcSEcCtD
Rifaximin—Myalgia—Doxorubicin—sarcoma	0.000495	0.000981	CcSEcCtD
Rifaximin—Chest pain—Doxorubicin—sarcoma	0.000495	0.000981	CcSEcCtD
Rifaximin—Arthralgia—Doxorubicin—sarcoma	0.000495	0.000981	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000492	0.000974	CcSEcCtD
Rifaximin—Discomfort—Doxorubicin—sarcoma	0.000489	0.000969	CcSEcCtD
Rifaximin—Anorexia—Epirubicin—sarcoma	0.000489	0.000969	CcSEcCtD
Rifaximin—Dry mouth—Doxorubicin—sarcoma	0.000484	0.000959	CcSEcCtD
Rifaximin—Hypotension—Epirubicin—sarcoma	0.000479	0.00095	CcSEcCtD
Rifaximin—Confusional state—Doxorubicin—sarcoma	0.000479	0.000948	CcSEcCtD
Rifaximin—Anaphylactic shock—Doxorubicin—sarcoma	0.000475	0.00094	CcSEcCtD
Rifaximin—Infection—Doxorubicin—sarcoma	0.000472	0.000934	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000467	0.000926	CcSEcCtD
Rifaximin—Shock—Doxorubicin—sarcoma	0.000467	0.000925	CcSEcCtD
Rifaximin—Nervous system disorder—Doxorubicin—sarcoma	0.000465	0.000922	CcSEcCtD
Rifaximin—Insomnia—Epirubicin—sarcoma	0.000464	0.000919	CcSEcCtD
Rifaximin—Skin disorder—Doxorubicin—sarcoma	0.000461	0.000913	CcSEcCtD
Rifaximin—Hyperhidrosis—Doxorubicin—sarcoma	0.000459	0.000909	CcSEcCtD
Rifaximin—Dyspnoea—Epirubicin—sarcoma	0.000457	0.000906	CcSEcCtD
Rifaximin—Anorexia—Doxorubicin—sarcoma	0.000452	0.000896	CcSEcCtD
Rifaximin—Decreased appetite—Epirubicin—sarcoma	0.000446	0.000884	CcSEcCtD
Rifaximin—Hypotension—Doxorubicin—sarcoma	0.000444	0.000879	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Epirubicin—sarcoma	0.000443	0.000877	CcSEcCtD
Rifaximin—Fatigue—Epirubicin—sarcoma	0.000442	0.000876	CcSEcCtD
Rifaximin—Pain—Epirubicin—sarcoma	0.000439	0.000869	CcSEcCtD
Rifaximin—Constipation—Epirubicin—sarcoma	0.000439	0.000869	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000432	0.000857	CcSEcCtD
Rifaximin—Insomnia—Doxorubicin—sarcoma	0.000429	0.000851	CcSEcCtD
Rifaximin—Dyspnoea—Doxorubicin—sarcoma	0.000423	0.000838	CcSEcCtD
Rifaximin—Feeling abnormal—Epirubicin—sarcoma	0.000423	0.000838	CcSEcCtD
Rifaximin—Gastrointestinal pain—Epirubicin—sarcoma	0.000419	0.000831	CcSEcCtD
Rifaximin—Decreased appetite—Doxorubicin—sarcoma	0.000413	0.000817	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00041	0.000812	CcSEcCtD
Rifaximin—Fatigue—Doxorubicin—sarcoma	0.000409	0.000811	CcSEcCtD
Rifaximin—Urticaria—Epirubicin—sarcoma	0.000408	0.000807	CcSEcCtD
Rifaximin—Pain—Doxorubicin—sarcoma	0.000406	0.000804	CcSEcCtD
Rifaximin—Constipation—Doxorubicin—sarcoma	0.000406	0.000804	CcSEcCtD
Rifaximin—Abdominal pain—Epirubicin—sarcoma	0.000406	0.000803	CcSEcCtD
Rifaximin—Body temperature increased—Epirubicin—sarcoma	0.000406	0.000803	CcSEcCtD
Rifaximin—Feeling abnormal—Doxorubicin—sarcoma	0.000391	0.000775	CcSEcCtD
Rifaximin—Gastrointestinal pain—Doxorubicin—sarcoma	0.000388	0.000769	CcSEcCtD
Rifaximin—Hypersensitivity—Epirubicin—sarcoma	0.000378	0.000749	CcSEcCtD
Rifaximin—Urticaria—Doxorubicin—sarcoma	0.000377	0.000747	CcSEcCtD
Rifaximin—Body temperature increased—Doxorubicin—sarcoma	0.000375	0.000743	CcSEcCtD
Rifaximin—Abdominal pain—Doxorubicin—sarcoma	0.000375	0.000743	CcSEcCtD
Rifaximin—Asthenia—Epirubicin—sarcoma	0.000368	0.000729	CcSEcCtD
Rifaximin—Pruritus—Epirubicin—sarcoma	0.000363	0.000719	CcSEcCtD
Rifaximin—Diarrhoea—Epirubicin—sarcoma	0.000351	0.000695	CcSEcCtD
Rifaximin—Hypersensitivity—Doxorubicin—sarcoma	0.00035	0.000693	CcSEcCtD
Rifaximin—Asthenia—Doxorubicin—sarcoma	0.000341	0.000675	CcSEcCtD
Rifaximin—Dizziness—Epirubicin—sarcoma	0.000339	0.000672	CcSEcCtD
Rifaximin—Pruritus—Doxorubicin—sarcoma	0.000336	0.000665	CcSEcCtD
Rifaximin—Vomiting—Epirubicin—sarcoma	0.000326	0.000646	CcSEcCtD
Rifaximin—Diarrhoea—Doxorubicin—sarcoma	0.000325	0.000643	CcSEcCtD
Rifaximin—Rash—Epirubicin—sarcoma	0.000323	0.000641	CcSEcCtD
Rifaximin—Dermatitis—Epirubicin—sarcoma	0.000323	0.00064	CcSEcCtD
Rifaximin—Headache—Epirubicin—sarcoma	0.000321	0.000637	CcSEcCtD
Rifaximin—Dizziness—Doxorubicin—sarcoma	0.000314	0.000622	CcSEcCtD
Rifaximin—Nausea—Epirubicin—sarcoma	0.000305	0.000604	CcSEcCtD
Rifaximin—Vomiting—Doxorubicin—sarcoma	0.000302	0.000598	CcSEcCtD
Rifaximin—Rash—Doxorubicin—sarcoma	0.000299	0.000593	CcSEcCtD
Rifaximin—Dermatitis—Doxorubicin—sarcoma	0.000299	0.000592	CcSEcCtD
Rifaximin—Headache—Doxorubicin—sarcoma	0.000297	0.000589	CcSEcCtD
Rifaximin—Nausea—Doxorubicin—sarcoma	0.000282	0.000559	CcSEcCtD
